Linked Life Data

12047796

Source:http://linkedlifedata.com/resource/pubmed/id/12047796

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-6-5
pubmed:abstractText
Cardiologists have traditionally focused on coronary narrowing as seen on angiography and have orientated treatment towards bypassing these lesions or widening them with angioplasty. In patients with stable coronary artery disease, percutaneous coronary interventions reliably relieve angina and myocardial ischemia, but do not prevent myocardial infarction or reduce mortality. Cholesterol lowering therapy has been shown, in several large, randomized trials reported over the past decade, to reduce mortality and coronary events, including the need for revascularization in a broad spectrum of patients. Mechanical and metabolic treatments for coronary disease should be used synergistically.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1061-5377
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
182-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:articleTitle
Mechanical or metabolic treatment for coronary disease: synergistic, not antagonistic, approaches.
pubmed:affiliation
Division of Cardiology Hartford Hospital and University of Connecticut School of Medicine, Hartford, Connecticut, USA.
pubmed:publicationType
Journal Article, Review